Journal of Orthopaedic Research® · 2015 · 28 citations · 19 references
MedicineOncologyPathologyCancer EpidemiologyMolecular OncologySurvival AnalysisCancer BiomarkersCancer Survival AnalysisInflammatory BiomarkersMalignant NeoplasmsSoft Tissue SarcomasTumor MarkersC-reactive Protein TestingDisease Prognostic BiomarkersDisease-specific SurvivalKaplan-meier Confidence IntervalsMultivariable Risk Prediction ModelsPrognostic BiomarkersPrognostic Marker EvaluationPrognostic Tumor Markers
Data on prognostic biomarkers in soft tissue sarcomas are scarce. The aim of the study was to define prognostic markers in patients with a liposarcoma, a subtype of sarcoma derived from adipose tissue. We restrospectively reviewed 85 patients with liposarcoma treated at our department from May 1994 to October 2011. Kaplan-Meier curves, uni-, and multivariable Cox proportional hazard models and competing risk analysis were performed to evaluate the association between putative biomarkers with disease-specific and overall survival. We observed a significant association between both alkalic phosphatase (ALP; subhazard ratio [SHR] per 1 unit increase: 1.35; 95%CI 1.10-1.65; p = 0.005) and C-reactive protein (CRP; SHR per 1 mg/dl increase: 2,57; 95%CI 1.36-4,86; p = 0.004) with disease-specific survival. Hemoglobin (Hb) (HR per 1 g/dl increase: 065; 95%CI 0.48-0.87; p = 0.003) was associated with overall survival. These associations prevailed after multivariable adjustment for AJCC tumor stage. This study identifies CRP and ALP as novel independent predictors of disease-specific survival in patients with liposarcoma.
19
Heinz Ludwig, Simon Van Belle, Peter Barrett‐Lee et al. · European Journal of Cancer · 2004 · 928 citations
Medicine, Hematology, Oncology +10